product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IL-1ra/IL-1F3 Protein, CF
catalog :
280-RA-010/CF
quantity :
10 ug (also 50 ug)
price :
355 USD
more info or order :
citations: 54
Reference
Fujita D, Matsuoka Y, Yamakita S, Horii Y, Ishikawa D, Kushimoto K, et al. Rapid cleavage of IL-1β in DRG neurons produces tissue injury-induced pain hypersensitivity. Mol Pain. 2024;20:17448069241285357 pubmed publisher
Morrison V, Houpert M, Trapani J, Brockman A, Kingsley P, Katdare K, et al. Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone. bioRxiv. 2023;: pubmed publisher
Kolganova M, Melnik E, Fisher E, Smirnov V, Vlasov A, Gegechkori V, et al. Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation. Biomedicines. 2022;10: pubmed publisher
Cluny N, Nyuyki K, Almishri W, Griffin L, Lee B, Hirota S, et al. Recruitment of α4β7 monocytes and neutrophils to the brain in experimental colitis is associated with elevated cytokines and anxiety-like behavior. J Neuroinflammation. 2022;19:73 pubmed publisher
Bernau K, Leet J, Floerke H, Bruhn E, Noll A, McDermott I, et al. Interleukin-1α Is a Critical Mediator of the Response of Human Bronchial Fibroblasts to Eosinophilic Inflammation. Cells. 2021;10: pubmed publisher
Dahl H, Kanchwala M, Thomas Jardin S, Sandhu A, Kanumuri P, Nawas A, et al. Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence. PLoS ONE. 2020;15:e0242970 pubmed publisher
Fan Y, Lee K, Tsai Y. Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression. Biomedicines. 2020;8: pubmed publisher
Namai F, Shigemori S, Ogita T, Sato T, Shimosato T. Microbial therapeutics for acute colitis based on genetically modified Lactococcus lactis hypersecreting IL-1Ra in mice. Exp Mol Med. 2020;52:1627-1636 pubmed publisher
Mohamed I, Sheibani N, El Remessy A. Deletion of Thioredoxin-Interacting Protein (TXNIP) Abrogates High Fat Diet-induced Retinal Leukostasis, Barrier Dysfunction and Microvascular Degeneration in a Mouse Obesity Model. Int J Mol Sci. 2020;21: pubmed publisher
Chen Y, Yang Z, Deng B, Wu D, Quan Y, Min Z. Interleukin 1β/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy. Oncol Rep. 2020;43:908-918 pubmed publisher
Murugina N, Budikhina A, Dagil Y, Maximchik P, Balyasova L, Murugin V, et al. Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia. J Biol Chem. 2020;295:3099-3114 pubmed publisher
Hook J, Cao M, Weng K, Kinnare N, Moreland J. Mycobacterium tuberculosis Lipoarabinomannan Activates Human Neutrophils via a TLR2/1 Mechanism Distinct from Pam3CSK4. J Immunol. 2020;204:671-681 pubmed publisher
Messerschmidt L, Fischer S, Wiedemann P, Bringmann A, Hollborn M. Osmotic induction of cyclooxygenase-2 in RPE cells: Stimulation of inflammasome activation. Mol Vis. 2019;25:329-344 pubmed
Lindblad A, Persson K, Demirel I. IL-1RA is part of the inflammasome-regulated immune response in bladder epithelial cells and influences colonization of uropathogenic E. coli. Cytokine. 2019;123:154772 pubmed publisher
Samelko L, Caicedo M, Jacobs J, Hallab N. Transition from metal-DTH resistance to susceptibility is facilitated by NLRP3 inflammasome signaling induced Th17 reactivity: Implications for orthopedic implants. PLoS ONE. 2019;14:e0210336 pubmed publisher
Kinnunen K, Piippo N, Loukovaara S, Hytti M, Kaarniranta K, Kauppinen A. Lysosomal destabilization activates the NLRP3 inflammasome in human umbilical vein endothelial cells (HUVECs). J Cell Commun Signal. 2017;11:275-279 pubmed publisher
Nishijima N, Hirai T, Misato K, Aoyama M, Kuroda E, Ishii K, et al. Human Scavenger Receptor A1-Mediated Inflammatory Response to Silica Particle Exposure Is Size Specific. Front Immunol. 2017;8:379 pubmed publisher
Song Y, Wang Y, Zhang Y, Geng W, Liu W, Gao Y, et al. Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells. J Cell Mol Med. 2017;21:1373-1387 pubmed publisher
Li Y, Oosting M, Smeekens S, Jaeger M, Aguirre Gamboa R, Le K, et al. A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans. Cell. 2016;167:1099-1110.e14 pubmed publisher
Stojkovic S, Kaun C, Basílio J, Rauscher S, Hell L, Krychtiuk K, et al. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Sci Rep. 2016;6:25171 pubmed publisher
Sun Y, Zhu D, Wang G, Wang D, Zhou H, Liu X, et al. Pro-Inflammatory Cytokine IL-1β Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma. PLoS ONE. 2015;10:e0132677 pubmed publisher
Larena M, Holmgren J, Lebens M, Terrinoni M, Lundgren A. Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling. J Immunol. 2015;194:3829-39 pubmed publisher
Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
Delaloye J, Filali Mouhim A, Cameron M, Haddad E, Harari A, Goulet J, et al. Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins. J Virol. 2015;89:3819-32 pubmed publisher
Sugita S, Kamao H, Iwasaki Y, Okamoto S, Hashiguchi T, Iseki K, et al. Inhibition of T-cell activation by retinal pigment epithelial cells derived from induced pluripotent stem cells. Invest Ophthalmol Vis Sci. 2015;56:1051-62 pubmed publisher
Yan X, Jiang E, Weng H. Activation of toll like receptor 4 attenuates GABA synthesis and postsynaptic GABA receptor activities in the spinal dorsal horn via releasing interleukin-1 beta. J Neuroinflammation. 2015;12:222 pubmed publisher
Foucher E, Blanchard S, Preisser L, Descamps P, Ifrah N, Delneste Y, et al. IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1α. Eur J Immunol. 2015;45:1092-102 pubmed publisher
Lee J, Heur M. Interleukin-1?-induced Wnt5a enhances human corneal endothelial cell migration through regulation of Cdc42 and RhoA. Mol Cell Biol. 2014;34:3535-45 pubmed publisher
Stojkovic S, Kaun C, Heinz M, Krychtiuk K, Rauscher S, Lemberger C, et al. Interleukin-33 induces urokinase in human endothelial cells--possible impact on angiogenesis. J Thromb Haemost. 2014;12:948-57 pubmed publisher
Issafras H, Corbin J, Goldfine I, Roell M. Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties. J Pharmacol Exp Ther. 2014;348:202-15 pubmed publisher
Suwara M, Green N, Borthwick L, Mann J, Mayer Barber K, Barron L, et al. IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol. 2014;7:684-93 pubmed publisher
Valcarcel M, Carrascal T, Crende O, Vidal Vanaclocha F. IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors. J Invest Dermatol. 2014;134:470-480 pubmed publisher
Kinoshita H, Hirata Y, Nakagawa H, Sakamoto K, Hayakawa Y, Takahashi R, et al. Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLoS ONE. 2013;8:e60914 pubmed publisher
Corvaisier M, Delneste Y, Jeanvoine H, Preisser L, Blanchard S, Garo E, et al. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLoS Biol. 2012;10:e1001395 pubmed publisher
Serelli Lee V, Ling K, Ho C, Yeong L, Lim G, Ho B, et al. Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1?. PLoS ONE. 2012;7:e39199 pubmed publisher
Schipper H, de Jager W, van Dijk M, Meerding J, Zelissen P, Adan R, et al. A multiplex immunoassay for human adipokine profiling. Clin Chem. 2010;56:1320-8 pubmed publisher
Lee W, Kang S, Choi J, Lee S, Shah K, Eynon E, et al. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood. 2010;115:530-40 pubmed publisher
Marotta D, Costa R, Motta E, Fernandes E, Medeiros R, Quintão N, et al. Mechanisms underlying the nociceptive responses induced by platelet-activating factor (PAF) in the rat paw. Biochem Pharmacol. 2009;77:1223-35 pubmed
Man P, Lawrence C. Interleukin-1 mediates the anorexic and febrile actions of galanin-like Peptide. Endocrinology. 2008;149:5791-802 pubmed publisher
Wilson H, Varcoe R, Stokes L, Holland K, Francis S, Dower S, et al. P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. Br J Pharmacol. 2007;151:115-27 pubmed
Fitzgerald D, Meade K, McEvoy A, Lillis L, Murphy E, MacHugh D, et al. Tumour necrosis factor-alpha (TNF-alpha) increases nuclear factor kappaB (NFkappaB) activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells. Vet Immunol Immunopathol. 2007;116:59-68 pubmed
Maedler K, Schumann D, Sauter N, Ellingsgaard H, Bosco D, Baertschiger R, et al. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes. 2006;55:2713-22 pubmed
Peng H, Erdmann N, Whitney N, Dou H, Gorantla S, Gendelman H, et al. HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia. 2006;54:619-29 pubmed
Hatfield K, Ryningen A, Corbascio M, Bruserud O. Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts. Int J Cancer. 2006;119:2313-21 pubmed
Janes K, Gaudet S, Albeck J, Nielsen U, Lauffenburger D, Sorger P. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell. 2006;124:1225-39 pubmed
Kao C, Chen Y, Thai P, Wachi S, Huang F, Kim C, et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol. 2004;173:3482-91 pubmed
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-54 pubmed
Morita K, Miyasako T, Kitayama S, Dohi T. Interleukin-1 inhibits voltage-dependent P/Q-type Ca2+ channel associated with the inhibition of the rise of intracellular free Ca2+ concentration and catecholamine release in adrenal chromaffin cells. Biochim Biophys Acta. 2004;1673:160-9 pubmed
Kawano Y, Fukuda J, Itoh H, Takai N, Nasu K, Miyakawa I. The effect of inflammatory cytokines on secretion of macrophage colony-stimulating factor and monocyte chemoattractant protein-1 in human granulosa cells. Am J Reprod Immunol. 2004;52:124-8 pubmed
Copeland S, Siddiqui J, Remick D. Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J Immunol Methods. 2004;284:99-106 pubmed
Liu R, Lioté F, Rose D, Merz D, Terkeltaub R. Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes. Arthritis Rheum. 2004;50:247-58 pubmed
Schaub F, Liles W, Ferri N, Sayson K, Seifert R, Bowen Pope D. Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha. Circ Res. 2003;93:515-22 pubmed
Park J, Kim Y, Jee Y, Myong N, Lee K. Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-alpha and interleukin-1 beta. Scand J Immunol. 2003;57:463-9 pubmed
Lindemann S, Tolley N, Dixon D, McIntyre T, Prescott S, Zimmerman G, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154:485-90 pubmed
product information
brand :
R&D Systems
master code :
280-RA/CF
SKU :
280-RA-010/CF
product name :
Recombinant Human IL-1ra/IL-1F3 Protein, CF
unit size :
10 ug (also 50 ug)
seo description :
The Recombinant Human IL-1ra/IL-1F3 Protein, CF from R&D Systems is derived from E. coli. The Recombinant Human IL-1ra/IL-1F3 Protein, CF has been validated for the following applications: Bioactivity.
target :
IL-1ra/IL-1F3
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
dilution :
Bioactivity
purity :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
species :
Human
theoretical molecular weight :
17 kDa
gene symbol :
IL1RN
details of functionality :
Measured by its ability to inhibit IL-1 alpha -dependent proliferation in D10.G4.1 mouse helper T cells. Symons, J.A. etáal . (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. etáal . (eds): IRL Press. 272. The ED50 for this effect is 5-40 ng/mL in the presence of 50 pg/mL of rhIL-1 alpha .
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
top caption :
Recombinant Human IL-1ra/IL-1F3 Protein Bioactivity
accessionNumbers :
P18510
applications :
Bioactivity
source :
E. coli-derived Recombinant Human IL-1ra/IL-1F3 Protein, CF
USD :
355 USD
alt names :
DIRA, ICIL-1RA, IL1F3, IL-1F3, IL-1ra, IL1RA, IL-1ra3, IL1RN, IL-1RN, interleukin 1 receptor antagonist, IRAP, MVCD4
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.